Aurinia Pharmaceuticals Inc

Historical 13F Holders

Symbol
AUPH
CUSIP
05156V102
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 05156V102 since 12/18/2024, largest first.

Filer % of Class Filed
Tang Capital Management LLC 13D/A
10.0% 6/4/2026
Event 6/2/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Armistice Capital, LLC 13G/A
4.5% 2/14/2025
Event 12/31/2024
ILJIN SNT Co., Ltd. 13D/A
4.4% 8/26/2026
Event 8/20/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 7 89.0 k $1.44 M
2026 Q2 293 81.2 M $1.47 B
2026 Q1 277 74.0 M $1.10 B
2025 Q4 274 72.6 M $1.15 B
2025 Q3 257 66.6 M $736 M
2025 Q2 237 59.4 M $503 M
2025 Q1 230 62.8 M $505 M
2024 Q4 219 58.5 M $525 M
2024 Q3 203 59.1 M $428 M
2024 Q2 188 57.5 M $328 M
2024 Q1 203 58.7 M $295 M
2023 Q4 219 57.7 M $519 M
2023 Q3 224 51.1 M $397 M
2023 Q2 226 50.3 M $488 M
2023 Q1 211 50.8 M $557 M
2022 Q4 218 54.1 M $234 M
2022 Q3 218 56.0 M $421 M
2022 Q2 224 50.8 M $511 M
2022 Q1 219 43.2 M $533 M
2021 Q4 238 43.1 M $985 M
2021 Q3 205 43.9 M $967 M
2021 Q2 194 49.4 M $641 M
2021 Q1 197 52.6 M $683 M
2020 Q4 171 61.0 M $844 M
2020 Q3 168 65.0 M $958 M
2020 Q2 153 58.8 M $956 M
2020 Q1 147 60.7 M $881 M
2019 Q4 143 49.0 M $993 M
2019 Q3 82 25.5 M $136 M
2019 Q2 89 30.3 M $200 M
2019 Q1 88 29.8 M $194 M
2018 Q4 69 22.3 M $152 M
2018 Q3 73 21.5 M $145 M
2018 Q2 77 21.3 M $122 M
2018 Q1 72 21.8 M $113 M
2017 Q4 77 23.8 M $108 M
2017 Q3 74 23.4 M $147 M
2017 Q2 80 23.2 M $142 M
2017 Q1 90 24.6 M $182 M
2016 Q4 32 8.63 M $18.1 M
2016 Q3 15 4.24 M $12.8 M
2016 Q2 14 7.07 M $20.1 M
2016 Q1 17 6.74 M $19.7 M
2015 Q4 16 6.73 M $16.8 M
2015 Q3 12 7.11 M $20.1 M
2015 Q2 13 7.22 M $21.7 M
2015 Q1 13 7.61 M $33.2 M
2014 Q4 11 8.48 M $30.7 M
2014 Q3 11 6.02 M $19.3 M